RIT biomedical engineering researchers develop new separation technique for lab-on-chip devices to distinguish cells ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching ...

Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial ...

COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral ...

Solgate - a biotech start-up based in Klosterneuburg, Austria - is accelerating the development of new therapies targeting solute carrier (SLC) transporters using automated liquid handling systems ...

Just as species adapt over generations, our body's cells accumulate DNA changes throughout life. Most are harmless, yet a few "driver" mutations give a cell a competitive edge and can spark cancer.

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...